[1] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[2] |
HOU Qiong, LIU Fei, CHEN Chuanrong.
Immunotherapy combined with anti-angiogenic drugs and chemotherapy in negative driver gene and advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 775-779.
|
[3] |
QIAO Hongliang, DING Ning, DENG Kaihong, LIU Binbin, DONG Chuanjiang, CHEN Xiaobo, ZOU Lili.
New progress in research on novel control strategies for methicillin-resistant staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 676-687.
|
[4] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[5] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[6] |
ZHOU Guangchen, LIU Yixi, ZHENG Yun.
Colorectal cancer and microRNA: research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 575-587.
|
[7] |
LI Wei, HU Jiali, WANG Kai, HE Yijing.
Research progress and prospect of immunotherapy in the treatment of melanoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1053-1064.
|
[8] |
MIN Hang, GUO Mengran, YE Yue, XU Xiaoshuang, ZHEN Donghu.
Research progress of thyroid dysfunctions during treatment with immune-checkpoint inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 223-229.
|
[9] |
WANG Qinglan.
Recent updates on drug-resistance mechanisms in Mycobacterium tuberculosis and the role of PE/PPE proteins in drug resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1043-1051.
|
[10] |
LU Chenyu, YANG Jun, LIU Yixi, ZHENG Yun.
Function and regulation of miRNAs associated with Parkinson's disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 775-783.
|
[11] |
WANG Cheng, MA Pengcheng, SUN Jianfang, LI Hongyang.
Research progress in the mechanism of BRAF inhibitor resistance in melanoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 576-583.
|
[12] |
WANG Aijuan, GUO Yiyun, WANG Zhiqiu.
Apatinib combined with capecitabine in the treatment of advanced triple-negative breast cancer as third-line therapy: An observational study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 433-439.
|
[13] |
ZHAO Quanming, YANG Yang.
Progress in drug therapy for advanced triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 475-480.
|
[14] |
CHANG Xiangxiang, WEI Zhongling, ZHENG Xingyuan, LI Huimin, HUANG Laiquan.
Progress in the treatment of multiple myeloma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 107-116.
|
[15] |
CHE Jinjing.
Application of biomarkers in clinical development of biologics and bioanalytical strategies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 22-31.
|